Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Shilpa Medicare Limited, commonly known as Shilpa Medicare, is a distinguished pharmaceutical company founded in 1987 and headquartered in Raichur, Karnataka, India. As a key player in Pharmaceutical Preparation Manufacturing, the company specialises in developing and producing high-quality Active Pharmaceutical Ingredients (APIs) and finished dosage formulations, with a strong focus on both oncology and non-oncology segments.
Renowned for its robust research and development capabilities, Shilpa Medicare provides innovative and cost-effective solutions across its core business areas, including Contract Research and Manufacturing Services (CRAMS) and biologics. With significant operations in India and an expanding global footprint, the company maintains stringent compliance with international regulatory standards, serving markets worldwide.
-5 vs industry average
Shilpa Medicare’s score of 37 is lower than 49% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Shilpa Medicare, a Pharmaceutical Preparation Manufacturing company headquartered in India, has set ambitious climate commitments. The company aims to be 100% powered by renewable sources by 2030 and achieve net-zero carbon emissions by 2050, encompassing all scopes.
In 2025, Shilpa Medicare reported Scope 1 emissions of approximately 2,614,100 kg CO2e and Scope 2 emissions of about 12,670,200 kg CO2e. For 2024, their Scope 1 emissions were around 3,690,310 kg CO2e, and Scope 2 emissions were approximately 20,389,900 kg CO2e. In 2023, the company's Scope 1 emissions were about 1,523,280 kg CO2e, with Scope 2 emissions at approximately 14,691,660 kg CO2e. In 2022, Shilpa Medicare reported Scope 1 emissions of approximately 1,523,280 kg CO2e, Scope 2 emissions of about 14,691,660 kg CO2e, and Scope 3 emissions of roughly 877,770 kg CO2e.
Shilpa Medicare Limited is also "Committed" to near-term targets with the Science Based Targets initiative (SBTi), as of May 2026. This commitment aligns with its broader net-zero ambition.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Shilpa Medicare’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more